![](https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/MDAngle_ASCO-BladderCancer-Tagawa-Q3_thumb_VIM.jpg)
ASCO 2024: Key Insights in Urothelial Carcinoma
Professor of Medicine & Urology, Co-Leader, Cancer Therapeutics Program, Meyer Cancer Center, Weill Cornell Medicine, NewYork-Presbyterian Medical Center, New York, NY Disclosure: Scott T. Tagawa, MD, has disclosed the following relevant financial …